146 related articles for article (PubMed ID: 26308219)
1. Use of Levetiracetam in Neonates in Clinical Practice: A Retrospective Study at a German University Hospital.
Neininger MP; Ullmann M; Dahse AJ; Syrbe S; Bernhard MK; Frontini R; Kiess W; Merkenschlager A; Thome U; Bertsche T; Bertsche A
Neuropediatrics; 2015 Oct; 46(5):329-34. PubMed ID: 26308219
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam: safety and efficacy in neonatal seizures.
Ramantani G; Ikonomidou C; Walter B; Rating D; Dinger J
Eur J Paediatr Neurol; 2011 Jan; 15(1):1-7. PubMed ID: 21094062
[TBL] [Abstract][Full Text] [Related]
3. Intravenous levetiracetam as treatment for status epilepticus.
Berning S; Boesebeck F; van Baalen A; Kellinghaus C
J Neurol; 2009 Oct; 256(10):1634-42. PubMed ID: 19458986
[TBL] [Abstract][Full Text] [Related]
4. Intravenous levetiracetam in clinical practice--Results from an independent registry.
Lang N; Esser W; Evers S; Kellinghaus C; Nguento A; Schlegel U; Gaida B; Gburek-Augustat J; Altenmüller DM; Burghaus L; Hoffmann F; Fiedler B; Bast T; Rehfeld T; Happe S; Seitz RJ; Boor R; Stephani U
Seizure; 2015 Jul; 29():109-13. PubMed ID: 26076852
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
Milligan TA; Hurwitz S; Bromfield EB
Neurology; 2008 Aug; 71(9):665-9. PubMed ID: 18725591
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of levetiracetam in the management of seizures in neonates.
Sedighi M; Asadi F; Moradian N; Vakiliamini M; Moradian M
Neurosciences (Riyadh); 2016 Jul; 21(3):232-5. PubMed ID: 27356654
[TBL] [Abstract][Full Text] [Related]
7. The treatment of neonatal seizures: focus on Levetiracetam.
Loiacono G; Masci M; Zaccara G; Verrotti A
J Matern Fetal Neonatal Med; 2016; 29(1):69-74. PubMed ID: 25385270
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam in children with refractory status epilepticus.
Gallentine WB; Hunnicutt AS; Husain AM
Epilepsy Behav; 2009 Jan; 14(1):215-8. PubMed ID: 18926926
[TBL] [Abstract][Full Text] [Related]
9. Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial.
Bähr O; Hermisson M; Rona S; Rieger J; Nussbaum S; Körtvelyessy P; Franz K; Tatagiba M; Seifert V; Weller M; Steinbach JP
Acta Neurochir (Wien); 2012 Feb; 154(2):229-35; discussion 235. PubMed ID: 21909835
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany.
Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E
Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573
[TBL] [Abstract][Full Text] [Related]
11. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
Fuller KL; Wang YY; Cook MJ; Murphy MA; D'Souza WJ
Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092
[TBL] [Abstract][Full Text] [Related]
12. Intravenous levetiracetam treatment in status epilepticus: A prospective study.
Atmaca MM; Orhan EK; Bebek N; Gurses C
Epilepsy Res; 2015 Aug; 114():13-22. PubMed ID: 26088881
[TBL] [Abstract][Full Text] [Related]
13. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
Perry MS; Benatar M
Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks.
Piña-Garza JE; Schiemann-Delgado J; Yang H; Duncan B; Hadac J; Hunter SJ
Clin Ther; 2010 Oct; 32(11):1935-50. PubMed ID: 21095488
[TBL] [Abstract][Full Text] [Related]
17. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
Baulac M; Brodie MJ; Elger CE; Krakow K; Stockis A; Meyvisch P; Falter U
Epilepsia; 2007 Mar; 48(3):589-92. PubMed ID: 17326794
[TBL] [Abstract][Full Text] [Related]
18. Levetiracetam extended release conversion to monotherapy for the treatment of patients with partial-onset seizures: a double-blind, randomised, multicentre, historical control study.
Chung S; Ceja H; Gawłowicz J; Avakyan G; McShea C; Schiemann J; Lu S
Epilepsy Res; 2012 Aug; 101(1-2):92-102. PubMed ID: 22516508
[TBL] [Abstract][Full Text] [Related]
19. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
[TBL] [Abstract][Full Text] [Related]
20. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures.
Maitre NL; Smolinsky C; Slaughter JC; Stark AR
J Perinatol; 2013 Nov; 33(11):841-6. PubMed ID: 24051577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
